Jacobs John C
SEC CIK 1820836 · EDGAR
BoughtSold
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +150.2K | 264.1K | +132% | $0 |
| D | 2026-03-05 | 2026-03-03 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $9.49 | -69.3K | 225.7K | -23% | -$657.5K |
| D | 2026-03-03 | 2026-03-01 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $10.14 | -38.5K | 225.7K | -15% | -$389.9K |
| D | 2026-03-03 | 2026-03-01 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +83.3K | 264.1K | +46% | $0 |
| D | 2026-01-26 | 2026-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $9.17 | -39.1K | 180.8K | -18% | -$358.8K |
| D | 2026-01-26 | 2026-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +83.2K | 219.9K | +61% | $0 |
| D | 2025-03-04 | 2025-03-01 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +83.3K | 175.2K | +91% | $0 |
| D | 2025-03-04 | 2025-03-01 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $8.33 | -38.5K | 136.7K | -22% | -$320.3K |
| D | 2025-01-27 | 2025-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | $0.00 | +83.2K | 130.7K | +175% | $0 |
| D | 2025-01-27 | 2025-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $9.55 | -38.9K | 91.8K | -30% | -$371.2K |
| D | 2024-01-25 | 2024-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | M - OptEx | — | +83.2K | 83.2K | New | — |
| D | 2024-01-25 | 2024-01-23 | NVAX | NOVAVAX INC | Jacobs John C | Pres, CEO, Dir | F - Tax | $4.26 | -40.1K | 43.1K | -48% | -$170.8K |
| D | 2022-08-16 | 2022-08-15 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +40.0K | 40.0K | New | +$328.8K |
| DM | 2022-08-16 | 2022-08-15 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $51.07 | -40.0K | 0 | -100% | -$2.04M |
| DM | 2022-06-16 | 2022-06-15 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $45.42 | -15.0K | 800 | -95% | -$681.3K |
| D | 2022-06-16 | 2022-06-15 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +15.0K | 15.0K | New | +$123.3K |
| D | 2022-06-14 | 2022-06-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +25.0K | 25.0K | New | +$205.5K |
| DM | 2022-06-14 | 2022-06-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $44.18 | -25.0K | 0 | -100% | -$1.10M |
| D | 2022-03-18 | 2022-03-16 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +15.0K | 15.0K | New | +$123.3K |
| D | 2022-03-18 | 2022-03-16 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $45.32 | -15.0K | 0 | -100% | -$679.8K |
| DM | 2022-03-16 | 2022-03-14 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $42.39 | -25.0K | 0 | -100% | -$1.06M |
| D | 2022-03-16 | 2022-03-14 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +25.0K | 25.0K | New | +$205.5K |
| DM | 2022-01-05 | 2022-01-03+ | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $45.16 | -28.7K | 0 | -100% | -$1.30M |
| DM | 2022-01-05 | 2022-01-03+ | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +28.7K | 18.1K | New | +$235.9K |
| D | 2021-12-29 | 2021-12-27 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $45.03 | -1,300 | 0 | -100% | -$58.5K |
| D | 2021-12-29 | 2021-12-27 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +1,300 | 1,300 | New | +$10.7K |
| DM | 2021-12-15 | 2021-12-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $38.21 | -25.0K | 0 | -100% | -$955.4K |
| D | 2021-12-15 | 2021-12-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +25.0K | 25.0K | New | +$205.5K |
| D | 2021-09-14 | 2021-09-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | S - Sale+OE | $35.93 | -25.0K | 0 | -100% | -$898.2K |
| D | 2021-09-14 | 2021-09-13 | HRMY | Harmony Biosciences Holdings, Inc. | Jacobs John C | Pres, CEO, Dir | M - OptEx | $8.22 | +25.0K | 25.0K | New | +$205.5K |
Purchase Sale Sale after option exercise All abbreviations